At today’s Capital Markets Day in
The updated strategic direction consists of a plan to approach clinical activities and includes several strategic initiatives, among these are:
- Continued investments into R&D to develop the next-generation technology
- Standardization of the product portfolio
- Further development of OEM (original equipment manufacturer) channels
- Strategic collaboration with
Mentice 's largest industry clients.
To support the strategic direction,
- 20-30 per cent annual growth in Net sales.
- EBITDA margin in the mid-term (three years) of 20 per cent with a longer-term target of 30 per cent EBITDA margin.
“This is formally our first capital market day since our IPO and we are looking forward to present strategi, product as well as two customer examples”, says Göran Malmberg,Mentice CEO, “we believe this is great opportunity to better explain whatMentice stand for.”
In addition to the management team, Dr
The event will take place from
During the event, there will be a demonstration of Mentices products and solutions and an opportunity to ask questions directly to any of the presenters. For a complete agenda and more information about the event and to register, please visit: https://www.mentice.com/event/cmd-2024
© Modular Finance, source